Literature DB >> 22036870

Rhodococcus equi pneumonia in the foal--part 2: diagnostics, treatment and disease management.

Gary Muscatello1.   

Abstract

Various challenges face clinicians and farm managers in diagnosing, treating and preventing Rhodococcus equi pneumonia. The use of ultrasound imaging has aided in the early diagnosis of the disease, reducing treatment duration and improving therapeutic outcomes. Antimicrobial resistance in R. equi is an emerging issue that necessitates prudent antimicrobial therapy of diseased foals. Alternative methods of disease transmission, such as contagious foal-to-foal aerosol transmission, may need to be addressed to complement dust reduction environmental strategies and to minimise the overall risk of exposure of foals to highly concentrated inhaled doses of the organism. Effective management of foals and land aimed at reducing aerosol exposure to virulent R. equi is likely to yield significant reductions in the prevalence and severity of R. equi pneumonia.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22036870     DOI: 10.1016/j.tvjl.2011.08.009

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  10 in total

1.  vanO, a new glycopeptide resistance operon in environmental Rhodococcus equi isolates.

Authors:  Dereje Dadi Gudeta; Arshnee Moodley; Valeria Bortolaia; Luca Guardabassi
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

2.  The effectiveness of anti-R. equi hyperimmune plasma against R. equi challenge in thoroughbred Arabian foals of mares vaccinated with R. equi vaccine.

Authors:  Osman Erganis; Zafer Sayin; Hasan Huseyin Hadimli; Asli Sakmanoglu; Yasemin Pinarkara; Ozgur Ozdemir; Mehmet Maden
Journal:  ScientificWorldJournal       Date:  2014-04-03

3.  Seroprevalence of <i>Rhodococcus equi</i> in horses in Israel.

Authors:  Sharon Tirosh-Levy; Sevil E Gürbilek; Osman Y Tel; Oktay Keskin; Amir Steinman
Journal:  J S Afr Vet Assoc       Date:  2017-06-26       Impact factor: 1.474

4.  Clinicopathological and radiographic features in 40 cats diagnosed with pulmonary and cutaneous Rhodococcus equi infection (2012-2018).

Authors:  Muhammad Waseem Aslam; Seng Fong Lau; Chelly Sze Lee Chin; Nur Indah Ahmad; Nor-Alimah Rahman; Krishnammah Kuppusamy; Sharina Omar; Rozanaliza Radzi
Journal:  J Feline Med Surg       Date:  2019-11-14       Impact factor: 2.015

5.  Rhodococcus equi-Derived Extracellular Vesicles Promoting Inflammatory Response in Macrophage through TLR2-NF-κB/MAPK Pathways.

Authors:  Zhaokun Xu; Xiujing Hao; Min Li; Haixia Luo
Journal:  Int J Mol Sci       Date:  2022-08-28       Impact factor: 6.208

6.  Minimum inhibitory concentrations of erythromycin and rifampin for Rhodococcus equi during the years 2007-2014.

Authors:  Caitriona S Fenton; Thomas C Buckley
Journal:  Ir Vet J       Date:  2015-10-06       Impact factor: 2.146

7.  Genotypic and phenotypic detection of efflux pump in Rhodococcus equi.

Authors:  Letícia Trevisan Gressler; Agueda Castagna de Vargas; Mateus Matiuzzi da Costa; Luciana Pötter; Bibiana Petri da Silveira; Luis Antônio Sangioni; Sônia de Avila Botton
Journal:  Braz J Microbiol       Date:  2014-08-29       Impact factor: 2.476

8.  Development and evaluation of the internal-controlled real-time PCR assay for Rhodococcus equi detection in various clinical specimens.

Authors:  Ilona Stefańska; Lucjan Witkowski; Magdalena Rzewuska; Tomasz Dzieciątkowski
Journal:  J Vet Med Sci       Date:  2015-12-08       Impact factor: 1.267

9.  A Common Practice of Widespread Antimicrobial Use in Horse Production Promotes Multi-Drug Resistance.

Authors:  S Álvarez-Narváez; L J Berghaus; E R A Morris; J M Willingham-Lane; N M Slovis; S Giguere; N D Cohen
Journal:  Sci Rep       Date:  2020-01-22       Impact factor: 4.379

10.  Opsonization but not pretreatment of equine macrophages with hyperimmune plasma nonspecifically enhances phagocytosis and intracellular killing of Rhodococcus equi.

Authors:  Aja B Harvey; Angela I Bordin; Joana N Rocha; Jocelyn M Bray; Noah D Cohen
Journal:  J Vet Intern Med       Date:  2020-12-16       Impact factor: 3.175

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.